Related Experiment Videos
Multiple endocrine neoplasia
Matthew L White1, Gerard M Doherty
1Department of Surgery, University of Michigan, and Department of Surgery, St. Joseph Mercy Hospital, 5301 McAuley Drive, Ann Arbor, MI 48197, USA.
Abstract:
MEN1 and MEN2 are autosomal dominant cancer syndromes with the potential for considerable morbidity and mortality. Better understanding of the molecular pathogenesis in MEN1 and MEN2 has fostered the development of specific DNA screening. Knowing the genetic status of patients is valuable for making decisions regarding surveillance and interventions, such as prophylactic thyroidectomy for medullary thyroid cancer. Identifying new RET pathways has provided molecular targets for therapies that currently are being tested in clinical trials for locally advanced, metastatic, and recurrent medullary thyroid cancer.
Insights
Multiple Endocrine Neoplasia (MEN1 and MEN2) are inherited cancer syndromes. Genetic screening aids in patient management and identifies new therapeutic targets for medullary thyroid cancer.
Area of Science:
- Endocrinology
- Oncology
- Genetics
Background:
- Multiple Endocrine Neoplasia (MEN1 and MEN2) are autosomal dominant cancer syndromes associated with significant morbidity and mortality.
- Understanding the molecular basis of these syndromes is crucial for developing effective management strategies.
Purpose of the Study:
- To highlight the importance of genetic screening in MEN1 and MEN2.
- To discuss the role of molecular targets in the treatment of medullary thyroid cancer.
Main Methods:
- Review of current understanding of MEN1 and MEN2 molecular pathogenesis.
- Discussion of DNA screening advancements.
- Overview of therapeutic strategies targeting RET pathways.
Main Results:
- Genetic status determination is vital for patient surveillance and interventions like prophylactic thyroidectomy.
- New RET pathways offer molecular targets for treating advanced, metastatic, and recurrent medullary thyroid cancer.
Conclusions:
- Genetic screening plays a critical role in managing MEN1 and MEN2.
- Targeted therapies for medullary thyroid cancer are under clinical investigation.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Smooth Endoplasmic Reticulum
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Endocrine Signaling
Endocrine Signaling
What is the Endocrine System?
Mitogens and the Cell Cycle